The new system, NAEOTOM Alpha.Prime, is expected to be operational by mid-July. Each year, about 2,500 tumor patients receive treatment at OncoRay’s Department of Radiation Oncology.
“In addition to enabling radiotherapy with fewer side effects, the PCCT images may even allow us to predict how the tumor will respond to therapy. Then, we can adapt the radiation treatment accordingly,” explained Prof. Esther Troost, Head of Image-Guided Radiooncology.
MEDICA-tradefair.com; Source: Helmholtz-Zentrum Dresden-Rossendorf